Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR: 4,210 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
4,210
Total FAERS Reports
415 (9.9%)
Deaths Reported
966
Hospitalizations
4,210
As Primary/Secondary Suspect
114
Life-Threatening
54
Disabilities
Prescription
Status

FDA Application: 761103 ·

First Report: 20020708 · Latest Report: 20250925

What Are the Most Common RITUXIMAB-PVVR Side Effects?

#1 Most Reported
Off label use
2,079 reports (49.4%)
#2 Most Reported
Intentional product use issue
627 reports (14.9%)
#3 Most Reported
Condition aggravated
514 reports (12.2%)

All RITUXIMAB-PVVR Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Off label use 2,079 49.4% 209 502
Intentional product use issue 627 14.9% 56 146
Condition aggravated 514 12.2% 26 147
Death 338 8.0% 338 63
Covid-19 322 7.7% 39 135
Fatigue 318 7.6% 15 84
Dyspnoea 314 7.5% 27 104
Inappropriate schedule of product administration 311 7.4% 21 77
Headache 291 6.9% 8 77
Pruritus 288 6.8% 4 35
Nausea 286 6.8% 8 76
Malaise 275 6.5% 28 95
Pain 271 6.4% 13 79
Throat irritation 259 6.2% 1 30
Cough 249 5.9% 15 64
Blood pressure fluctuation 241 5.7% 20 44
Product use issue 221 5.3% 27 51
Blood pressure increased 215 5.1% 10 54
Pneumonia 213 5.1% 35 128
Drug ineffective 210 5.0% 7 46

Who Reports RITUXIMAB-PVVR Side Effects? Age & Gender Data

Gender: 67.9% female, 32.1% male. Average age: 60.4 years. Most reports from: CA. View detailed demographics →

Is RITUXIMAB-PVVR Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 1 0 1
2014 1 0 1
2015 3 0 0
2016 1 0 1
2017 4 0 3
2018 8 0 5
2019 6 1 2
2020 84 7 14
2021 484 75 120
2022 666 75 203
2023 856 72 206
2024 733 66 183
2025 336 18 101

View full timeline →

What Is RITUXIMAB-PVVR Used For?

IndicationReports
Rheumatoid arthritis 1,659
Granulomatosis with polyangiitis 745
Microscopic polyangiitis 174
Multiple sclerosis 106
Systemic lupus erythematosus 105
Interstitial lung disease 73
Glomerulonephritis membranous 65
Anti-neutrophil cytoplasmic antibody positive vasculitis 62
Sjogren's syndrome 54
Product used for unknown indication 52

RITUXIMAB-PVVR vs Alternatives: Which Is Safer?

RITUXIMAB-PVVR vs RIVAROXABAN RITUXIMAB-PVVR vs RIVASTIGMINE RITUXIMAB-PVVR vs RIVOTRIL RITUXIMAB-PVVR vs RIZATRIPTAN RITUXIMAB-PVVR vs ROACTEMRA RITUXIMAB-PVVR vs ROCURONIUM RITUXIMAB-PVVR vs ROFECOXIB RITUXIMAB-PVVR vs ROFLUMILAST RITUXIMAB-PVVR vs ROLAPITANT RITUXIMAB-PVVR vs ROMIDEPSIN

Official FDA Label for RITUXIMAB-PVVR

Official prescribing information from the FDA-approved drug label.